Manchester Financial Inc. Purchases 1,235 Shares of HCA Healthcare, Inc. $HCA

Manchester Financial Inc. boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 26.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,900 shares of the company’s stock after acquiring an additional 1,235 shares during the period. HCA Healthcare makes up approximately 0.4% of Manchester Financial Inc.’s investment portfolio, making the stock its 26th largest holding. Manchester Financial Inc.’s holdings in HCA Healthcare were worth $2,300,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Palisade Asset Management LLC acquired a new stake in HCA Healthcare during the 3rd quarter worth approximately $26,000. MidFirst Bank bought a new stake in HCA Healthcare in the 2nd quarter valued at $28,000. Clearstead Trust LLC bought a new position in HCA Healthcare during the 2nd quarter worth about $29,000. Cedar Mountain Advisors LLC acquired a new position in shares of HCA Healthcare during the first quarter worth about $33,000. Finally, JPL Wealth Management LLC acquired a new position in HCA Healthcare during the 3rd quarter worth approximately $33,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $417.57 on Friday. HCA Healthcare, Inc. has a 1 year low of $353.99 and a 1 year high of $556.52. The company has a market capitalization of $90.40 billion, a price-to-earnings ratio of 13.98, a P/E/G ratio of 1.46 and a beta of 1.10. The business has a fifty day simple moving average of $401.08 and a two-hundred day simple moving average of $441.46.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. During the same period in the prior year, the firm earned $6.84 earnings per share. The company’s revenue was up 8.7% on a year-over-year basis. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 29.42 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be given a $0.78 dividend. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio is presently 10.45%.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. Oppenheimer decreased their target price on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a research report on Monday, July 27th. KeyCorp lowered their target price on HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating on the stock in a research report on Monday, July 27th. Mizuho decreased their target price on shares of HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating for the company in a research note on Tuesday, July 28th. Sanford C. Bernstein reiterated a “market perform” rating on shares of HCA Healthcare in a research note on Wednesday, July 15th. Finally, Barclays lowered their price objective on shares of HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating on the stock in a research note on Monday, July 27th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $462.64.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.